Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




MRI and CT Predicts Flap Failure After Head and Neck Reconstructive Cancer Surgery

By HospiMedica International staff writers
Posted on 24 Jun 2022

When a patient with head and neck cancer has surgery to remove it, they often need reconstructive surgery in the form of a “free flap”, which is skin and tissue taken from a different part of the body and connected to the blood vessels of the wound in need of repair. More...

This free flap method, called microvascular reconstruction, carries around a 10-40% risk of wound complications, with 10% of cases requiring another surgery. Currently, most surgeons use ultrasound to assess viability for free flap reconstruction with techniques known as Doppler and skin paddle. Those methods often are unable to evaluate deeper aspects of the flap, or air and blood products cause interference in visualization, which affects how well clinicians can analyze a flap’s viability. Now, a study has found that early postoperative CT scans and MRIs can help predict whether a flap will fail, which could allow surgeons to intervene earlier.

In the study, a team of researchers from the University of Michigan Health (Ann Arbor, MI, USA) analyzed 19 patients who had successful free flap reconstruction, as well as five who had wound failure, between January 2016 to mid-2018. They found that both CT and MRI perfusion techniques showed significant differences between the two patient groups. Researchers were not able to compare the two methods to ultrasound techniques or each other due to the small sample size. They hope to accomplish those comparisons through a larger future trial.

“All patients who have this procedure can be investigated with non-invasive post-operative CT or MRI perfusion, and these two methods show a lot of promise as accurate biomarkers of predicting free flap viability,” said Ashok Srinivasan, M.D., FACR, a neuroradiologist at University of Michigan Health.

“This pilot research shows us that these models work, as all areas of the flap can be assessed using CT and MRI, unlike doppler and skin paddle where some areas may be blind to evaluation,” said Yoshiaki Ota, M.D., a neuroradiology fellow at University of Michigan Health. “We know that using CT and MRI could help shorten a patient’s hospital stay or avoid a prolonged hospitalization, and now we need to look further at which is more effective and cost-effective.”

Related Links:
University of Michigan Health 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.